Silver Book Fact

The annual burden to the U.S. economy of age-related macular degeneration (AMD), cataract, diabetic retinopathy, glaucoma, refractive errors, visual impairment, and blindness in adults age 40 and older is estimated at $35.4 billion– $16.2 billion in direct medical costs, $11.1 billion in other direct costs, and $8 billion in lost productivity.

Rein D, Zhang P, Wirth K, Lee P, et al. The Economic Burden of Major Adult Visual Disorders in the United States. Arch Opthalmol. 2006; 124(12): 1754-60. http://archopht.ama-assn.org/cgi/content/abstract/124/12/1754

Reference

Title
The Economic Burden of Major Adult Visual Disorders in the United States
Publication
Arch Opthalmol
Publication Date
2006
Authors
Rein D, Zhang P, Wirth K, Lee P, et al
Volume & Issue
Volume 124, Issue 12
Pages
1754-60
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Longitudinal study on vision loss in Medicare patients
    A longitudinal study that followed Medicare patients found that after 9 years, almost 50% of survivors had developed glaucoma, cataract, or macular degeneration.  
  • The annual direct medical costs (including outpatient, inpatient, and prescription drug services) for Americans age 40 and older with glaucoma is $2.86 billion.  
  • Diabetic retinopathy often causes vision loss and blindness during working age years, resulting in more disability and person-years of vision lost than other eye diseases.  
  • People Affected Worldwide by DR
    By 2030, more than 191 million people around the world will be affected by DR—56 million with vision-threatening DR.  
  • Americans age 80 and older have the highest rates of blindness. They are also the fastest growing segment of our population.